๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

RASMutations Predict Radiologic and Pathologic Response in Patients Treated with Chemotherapy Before Resection of Colorectal Liver Metastases

โœ Scribed by Mise, Yoshihiro; Zimmitti, Giuseppe; Shindoh, Junichi; Kopetz, Scott; Loyer, Evelyne M.; Andreou, Andreas; Cooper, Amanda B.; Kaur, Harmeet; Aloia, Thomas A.; Maru, Dipen M.; Vauthey, Jean-Nicolas

Book ID
127159800
Publisher
Springer
Year
2014
Tongue
English
Weight
547 KB
Volume
22
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Bevacizumab improves pathologic response
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases
โœ Dario Ribero; Huamin Wang; Matteo Donadon; Daria Zorzi; Melanie B. Thomas; Cathy ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 271 KB

## Abstract ## BACKGROUND. The current study evaluated the effect of bevacizumab added to fluoropyrimidineโ€plusโ€oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases (CLM) on the pathologic response and nontumorous liver histology. ## METHODS. A total of 105 consecutive patients trea